Publications GFPC

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP
08–02 study


Lien :

Télécharger : esogia2def


Sebastien Gendarme, Sonia Zebachi, Romain Corre, Laurent Greillier, Gregoire Justeau, Olivier Bylicki, Chantal Decroisette, Jean-Bernard Auliac, Florian Guisier, Margaux Geier, Charles Ricordel, Maxime Frelaut, Elena Paillaud, Christos Chouaïd, Florence Canouï-Poitrine


Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo)


Lien :

Télécharger : VMAarticle


Alain Vergnenegre, Isabelle Monnet, Charles Ricordel, Acya Bizieux, Hubert Curcio, Marie Bernardi, Romain Corre, Florian Guisier, Stephane Hominal, Gwenaelle Le Garff, Olivier Bylicki, Chrystele Locher, Margaux Geier, Christos Chouaïd, Gilles Robinet, the GFPC team


Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IVnon-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018


Lien :

Télécharger : Article


Olivier Bylicki, Pascale Tomasini, Gervais Radj, Florian Guisier, Isabelle Monnet, Charles Ricordel, Laurence Bigay-Game, Margaux Geier, Christos Chouaid, Catherine Daniel, Aurelie Swalduz, Anne-Claire Toffart, Helene Doubre, Jean-Michel Peloni, Diane Moreau, Fabien Subtil, Jean-Michel Grellard, Marie Castera, Benedicte Clarisse, Pedro-Henrique Martins-Lavinas, Chantal Decroisette, Laurent Greillier on behalf of GFPC